Why the study?
Sedation during PVI for AF often lowers LAP below atmospheric pressure, increasing the risk of systemic air embolisms, prompting evaluation of ASV efficacy on LAP.
Does adaptive servo-ventilation increase left atrial pressure in sedated patients undergoing cryoballoon pulmonary vein isolation for atrial fibrillation?
Does adaptive servo-ventilation increase left atrial pressure in sedated patients undergoing cryoballoon pulmonary vein isolation for atrial fibrillation?
Adaptive servo-ventilation effectively increases left atrial pressure above atmospheric levels in sedated patients undergoing cryoballoon pulmonary vein isolation, potentially reducing the risk of systemic air embolism.
Answers are grounded in this paper and cite their sources.
May support ASV to prevent negative LAP during sedated AF ablation; leaves open whether this reduces embolism risk in randomized trials.
BACKGROUND: Sedation during pulmonary vein isolation (PVI) for atrial fibrillation often provokes a decline in left atrial (LA) pressure (LAP) under atmospheric pressure and increases the risk of systemic air embolisms. This study aimed to investigate the efficacy of adaptive servo-ventilation (ASV) on the LAP in sedated patients. METHODS AND RESULTS: Fifty-one consecutive patients undergoing cryoballoon PVI were enrolled. All patients underwent sedation using propofol throughout the procedure. After the transseptal puncture and the insertion of a long sheath into the LA, the LAP was measured. Then, the ASV treatment was started, and the LAP was re-measured. The LAP before and after the ASV support was investigated. Before ASV, the LAP during the inspiratory phase was significantly smaller than that during the expiratory phase (4.9±5.4 mmHg vs. 14.0±5.2 mmHg, P<0.01). The lowest LAP was -2.2±5.1 mmHg and was under 0 mmHg in 37 (73%) patients. After the ASV, the LAP during the inspiratory phase significantly increased to 8.9±4.1 mmHg (P<0.01), and lowest LAP increased to 4.7±5.9 mmHg (P<0.01). The negative lowest LAP value became positive in 30/37 (81%) patients. There were no statistical differences regarding obstructive sleep apnea (OSA), obesity, gender, or other comorbidities between patients with and without a negative lowest LAP after ASV support. CONCLUSIONS: ASV is effective for increasing the LAP above 0 mmHg and might prevent air embolisms during PVI.
No takes yet. Share an insight, caveat, or question.
Kawaguchi et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: